Literature DB >> 6782787

Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrations.

L A Håkan Borg, A Andersson.   

Abstract

In order to evaluate long-term effects of sulphonylureas on pancreatic islet structure and function, isolated mouse islets were maintained in tissue culture for one week at various glucose concentrations, and in the absence or presence of glibenclamide. When the islets were cultured at 3.3 or 5.5 mmol/1, but not at 16.7 mmol/1 glucose, it was found that the drug stimulated insulin secretion into the culture medium during the initial 3 days of culture. During the remainder of the culture period no such enhancement of secretion was demonstrated. Insulin release due to glibenclamide apparently resulted in rapid depletion of intracellular insulin stores. The finding of an enlarged B-cell Golgi apparatus in the drug-treated islets was probably associated with granule discharge. The failure of glibenclamide to promote insulin secretion during the whole culture period could reflect the adverse effects of the drug on islet insulin biosynthesis as indicated by short-term experiments performed after culture. Similar experiments showed that the impaired insulin biosynthesis could not be restored by withdrawal of the drug from the culture medium for 3 days. Furthermore, the capacity for insulin release in response to an acute glucose challenge at the end of the culture period, was abolished by culture in the presence of glibenclamide. The drug effects on insulin biosynthesis and intracellular insulin stores, which were most pronounced at 5.5 mmol/1 glucose, possibly resulted from changes in B-cell metabolism as suggested by the diminished islet glucose-oxidation rate. The spatial characteristics of islet mitochondria indicated that these changes might involve an adaptation to substrates other than glucose. In conclusion, our findings suggest that sulphonylureas have an insulinotropic effect, which is however transient. Indeed, it rather seems as if long-term exposure of islet B-cells to sulphonylureas in vitro were accompanied by functional deficiency.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6782787     DOI: 10.1007/BF02056108

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  67 in total

1.  The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.

Authors:  B Hellman; J Sehlin; I B Täljedal
Journal:  Diabetologia       Date:  1973-06       Impact factor: 10.122

2.  [Experimental study on glibenclamide (HB 419), a new particularly active hypoglycaemic sulphonamide. II. Betacytotrophic action and stimulation of the neogenesis of the islets of Langerhans].

Authors:  A Loubatières; M M Mariani; R Alric; G Ribes; H de Malbosc; M H Houareau
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

3.  [Stimulation of insulin secretion in vitro by a new, highly-active antidiabetic].

Authors:  H Schwarz; J Ammon; J E Yeboah; H E Hildebrandt; E F Pfeiffer
Journal:  Diabetologia       Date:  1968-01       Impact factor: 10.122

4.  [Clinico-pharmacological studies on the blood sugar reducing effect of HB 419 in healthy people].

Authors:  G Betzien
Journal:  Arzneimittelforschung       Date:  1969-08

5.  [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].

Authors:  K Schöffling; R Petzoldt; C Althoff-Zucker; J Beyer; K Retiene; E Böhle; W Kunkel
Journal:  Arzneimittelforschung       Date:  1969-08

6.  Effects of glycodiazin and glybenclamide upon insulin secretion in vitro.

Authors:  W Malaisse; F Malaisse-Lagae
Journal:  Eur J Pharmacol       Date:  1970-01       Impact factor: 4.432

7.  [Ultrastructural study of the stimulation process of insular neoformation observed in rats chronically treated with glibenclamide].

Authors:  A Loubatières; Y Atech
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1972-09-18

8.  Effects of sulfonylureas on histochemical and ultracytochemical calcium distribution in B-cells of mice.

Authors:  G Klöppel; H J Schäfer
Journal:  Diabetologia       Date:  1976-07       Impact factor: 10.122

9.  An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals.

Authors:  J C Dunbar; P P Foà
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  11 in total

1.  Characterization of the action of S 21403 (mitiglinide) on insulin secretion and biosynthesis in normal and diabetic beta-cells.

Authors:  Nurit Kaiser; Rafael Nesher; Andrei Oprescu; Suad Efendic; Erol Cerasi
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 2.  Pancreatic beta-cell growth and diabetes mellitus.

Authors:  I Swenne
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

Review 3.  Interaction of sulfonylurea with the pancreatic B-cell.

Authors:  E Gylfe; B Hellman; J Sehlin; B Täljedal
Journal:  Experientia       Date:  1984-10-15

4.  Relationships between the Na(+)/K(+) pump and ATP and ADP content in mouse pancreatic islets: effects of meglitinide and glibenclamide.

Authors:  A Elmi; L A Idahl; J Sehlin
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

5.  Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.

Authors:  M Anello; P Gilon; J C Henquin
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

6.  Autoantibodies directed against glutamate decarboxylase interfere with glucose-stimulated insulin secretion in dispersed rat islets.

Authors:  Varun Kamat; Jared R Radtke; Qingxun Hu; Wang Wang; Ian R Sweet; Christiane S Hampe
Journal:  Int J Exp Pathol       Date:  2022-03-04       Impact factor: 2.793

7.  Long-term effects of cyclosporin A on cultured mouse pancreatic islets.

Authors:  A Andersson; H Borg; A Hallberg; C Hellerström; S Sandler; A Schnell
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  TGF-beta1 and high levels of glucose do not increase insulin cell proportions in the avian embryonic pancreas.

Authors:  A Marais; P T Goven-Shiba; B Kramer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-12-20       Impact factor: 2.416

9.  Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice.

Authors:  E Montaña; S Bonner-Weir; G C Weir
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Lysosomes and pancreatic islet function. Glucose-dependent alterations of lysosomal morphology.

Authors:  A H Schnell; L A Borg
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.